Biology:Involucrin

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example
Involucrin of squamous epithelia N-terminus
Identifiers
SymbolInvolucrin_N
PfamPF10583
InterProIPR019571
Involucrin repeat
Identifiers
SymbolInvolucrin
PfamPF00904
InterProIPR000354
SCOP21eu0 / SCOPe / SUPFAM
Involucrin repeat
Identifiers
SymbolInvolucrin2
PfamPF06994
InterProIPR009733

Involucrin is a protein component of human skin and in humans is encoded by the IVL gene.[1][2] In binding the protein loricrin, involucrin contributes to the formation of a cell envelope that protects corneocytes in the skin.

Gene

This gene is mapped to 1q21, among calpactin I light chain, trichohyalin, profillaggrin, loricrin, and calcyclin.[2]

Function

Involucrin is a highly reactive, soluble, transglutaminase substrate protein present in keratinocytes of epidermis and other stratified squamous epithelia.[3][4] It first appears in the cell cytosol, but ultimately becomes cross-linked to membrane proteins by transglutaminase thus helping in the formation of an insoluble envelope beneath the plasma membrane functioning as a glutamyl donor during assembly of the cornified envelope.[5]

Involucrin is synthesised in the stratum spinosum and cross linked in the stratum granulosum by the transglutaminase enzyme that makes it highly stable. Thus it provides structural support to the cell, thereby allowing the cell to resist invasion by micro-organisms.[citation needed]

Apigenin, a plant-derived flavanoid that has significant promise as a skin cancer chemopreventive agent, has been found to regulate normal human keratinocyte differentiation by suppressing involucrin, and this is associated with reduced cell proliferation without apoptosis.[6]

Clinical significance

As one of the precursor proteins of the cornified cell envelope, involucrin is markedly increased in inflammatory skin diseases such as psoriasis[7]

Lamellar ichthyosis involves a decrease in expression of involucrin. This decrease could contribute to the altered desquamation process seen in the disease, since the clinical improvement associated with retinoid treatment is accompanied by increased expression of involucrin.[8]

Structure

Involucrin consists of a conserved N-terminal region of about 75 amino acid residues followed by two extremely variable length segments that contain glutamine-rich tandem repeats. The glutamine residues in the tandem repeats are the substrate for the transglutaminase in the cross-linking reaction. The total size of the protein varies from 285 residues (in dog) to 835 residues (in orangutan).[citation needed]

References

  1. "Structure and evolution of the human involucrin gene". Cell 46 (4): 583–9. August 1986. doi:10.1016/0092-8674(86)90884-6. PMID 2873896. 
  2. 2.0 2.1 "Entrez Gene: IVL involucrin". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3713. 
  3. "Consecutive actions of different gene-altering mechanisms in the evolution of involucrin". Molecular Biology and Evolution 9 (6): 977–1017. November 1992. doi:10.1093/oxfordjournals.molbev.a040775. PMID 1359382. 
  4. "The involucrin genes of the mouse and the rat: study of their shared repeats". Molecular Biology and Evolution 10 (6): 1136–49. November 1993. doi:10.1093/oxfordjournals.molbev.a040069. PMID 8277848. 
  5. "Involucrin--structure and role in envelope assembly". The Journal of Investigative Dermatology 100 (5): 613–7. May 1993. doi:10.1111/1523-1747.ep12472288. PMID 8098344. 
  6. "Apigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cdelta Tyr311". The Journal of Biological Chemistry 281 (47): 36162–72. November 2006. doi:10.1074/jbc.M605368200. PMID 16982614. 
  7. "Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes". Journal of Dermatological Science 39 (3): 175–82. September 2005. doi:10.1016/j.jdermsci.2005.03.006. PMID 16140218. 
  8. "Altered expression of immunoreactive involucrin in lamellar ichthyosis". European Journal of Dermatology 9 (3): 197–201. 1999. PMID 10210784. http://www.john-libbey-eurotext.fr/medline.md?issn=1167-1122&vol=9&iss=3&page=197. 

Further reading

This article incorporates text from the public domain Pfam and InterPro: IPR019571